339 related articles for article (PubMed ID: 10453040)
1. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro.
Gharavi AE; Pierangeli SS; Colden-Stanfield M; Liu XW; Espinola RG; Harris EN
J Immunol; 1999 Sep; 163(5):2922-7. PubMed ID: 10453040
[TBL] [Abstract][Full Text] [Related]
2. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models.
Pierangeli SS; Liu X; Espinola R; Olee T; Zhu M; Harris NE; Chen PP
Thromb Haemost; 2000 Sep; 84(3):388-95. PubMed ID: 11019960
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Pierangeli SS; Espinola R; Liu X; Harris EN; Salmon JE
Arthritis Rheum; 2001 Apr; 44(4):876-83. PubMed ID: 11315927
[TBL] [Abstract][Full Text] [Related]
4. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.
Pierangeli SS; Blank M; Liu X; Espinola R; Fridkin M; Ostertag MV; Roye-Green K; Harris EN; Shoenfeld Y
J Autoimmun; 2004 May; 22(3):217-25. PubMed ID: 15041042
[TBL] [Abstract][Full Text] [Related]
5. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes.
Levine JS; Subang R; Koh JS; Rauch J
J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
7. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
8. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
10. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model.
Ferrara DE; Liu X; Espinola RG; Meroni PL; Abukhalaf I; Harris EN; Pierangeli SS
Arthritis Rheum; 2003 Nov; 48(11):3272-9. PubMed ID: 14613293
[TBL] [Abstract][Full Text] [Related]
12. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
Kuwana M
Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
[TBL] [Abstract][Full Text] [Related]
13. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
[TBL] [Abstract][Full Text] [Related]
14. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.
Atsumi T; Amengual O; Yasuda S; Matsuura E; Koike T
Autoimmunity; 2005 Aug; 38(5):377-81. PubMed ID: 16227153
[TBL] [Abstract][Full Text] [Related]
15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
16. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.
Gharavi AE; Vega-Ostertag M; Espinola RG; Liu X; Cole L; Cox NT; Romagnoli P; Labat K; Pierangeli SS
Lupus; 2004; 13(1):17-23. PubMed ID: 14870913
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo.
Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN
Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
